Fenwick & West represented Attovia Therapeutics in the transaction. Attovia Therapeutics, a clinical-stage biopharma company developing treatments for immune-mediated diseases, announced it raised $90 million in…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
